New Delhi, December 15, 2016: A case study from Astellas Pharma Tech Co. Ltd., Japan, describes how Cobalt’s RapID verifies the ID of raw materials through unopened paper and polyethylene sacks. Without the need to open and move containers manpower costs were reduced by more than 90% compared to existing pharmacopoeia testing methods. An additional benefit was the complete avoidance of foreign material and microbial contamination risk.
This study was part of an investigation to determine how to guarantee effective identification of packaged raw materials, in line with PIC/S GMP Annex 8 requirements. A translated excerpt of the original article, published in Japanese in the Pharm Tech Japan journal, is available for download from the Cobalt website.
Corporate Comm India(CCI Newswire)
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…